Pre-reading
Wearable Cardioverter-Defibrillator & Sudden Cardiac Death
JOURNAL:CBSMD
Evolving TAVR Populations: Questions and Challenges Remain
JOURNAL:ACC
Should the 10-Year Results From the SYNTAX Trial Redefine Who We Consider for CABG?
JOURNAL:ACC
Artificial Intelligence in Interventional Cardiology
JOURNAL:ACC
Vericiguat Improves Outcomes in Patients with Worsening Heart Failure
JOURNAL:www.dicardiology.com
Timing of Intervention in Asymptomatic Patients With Valvular Heart Disease
JOURNAL:ACC
Considerations for Optimal Device Selection in TAVR
JOURNAL:ACC
ESC Consensus on HFpEF Diagnosis: Key Points
JOURNAL:ACC
The 12 Month Prognosis Treated with Balloon-Expandable TAVR Superior to SAVR in Intermediate Risk Patients with Severe Aortic Stenosis
JOURNAL:ACC
Atrial Fibrillation and the Risk of Heart Failure
JOURNAL:CBSMD